|
HS Code |
233570 |
| Cas Number | 302-84-1 |
| Molecular Formula | C3H7NO3 |
| Molecular Weight | 105.09 g/mol |
| Synonyms | DL-2-Amino-3-hydroxypropionic acid |
| Appearance | White crystalline powder |
| Solubility | Soluble in water |
| Melting Point | 222°C (dec.) |
| Ph 1 Solution | 5.0-6.0 |
| Purity | Typically ≥98% |
| Storage Temperature | Room temperature |
As an accredited Dl-Serine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | DL-Serine is packaged in a white, sealed plastic bottle labeled with product details, containing 500 grams of fine white powder. |
| Shipping | Dl-Serine is shipped in tightly sealed containers to prevent contamination and moisture absorption. Packaging complies with safety standards, typically using bottles or drums made from material compatible with amino acids. It is transported at ambient temperature, with clear labeling for handling and chemical identification, ensuring safe and secure delivery to its destination. |
| Storage | **Dl-Serine** should be stored in a tightly sealed container, kept in a cool, dry, and well-ventilated area. Protect it from moisture, direct sunlight, and sources of ignition. Store away from incompatible substances such as strong oxidizers. Ideally, storage should be at room temperature (approximately 20–25°C). Ensure all containers are clearly labeled and follow local regulations for chemical storage. |
Competitive Dl-Serine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
DL-Serine stands as one of the core amino acid products used across numerous labs and industrial applications. As a manufacturer deeply rooted in the amino acids field, we know this molecule well—from raw material sourcing to final product testing. We see consistent demand for DL-Serine from pharmaceutical, food, and biotech partners who rely on its performance and purity. Understanding why this amino acid is sought after, and recognizing what sets our DL-Serine apart from other forms, helps our customers make informed decisions in their projects.
DL-Serine (C3H7NO3), with its molecular weight of 105.09, brings both the D- and L-isomer forms in a 1:1 ratio. That means in every batch, users work with a racemic mixture—half L-Serine, which naturally occurs in proteins of living organisms, and half D-Serine, more commonly applied in research exploring the functions of neurotransmitters. For many synthesis projects and chemical processes, this racemic form cuts costs compared to preserving or separating enantiomers.
Producing consistent, high-quality DL-Serine requires getting details right at each stage. Raw material selection starts the process. We work with carefully vetted suppliers who meet strict amino acid input criteria and have a proven supply history. Each intake batch is inspected for trace contaminants, moisture levels, and analytical consistency before entering our reactors.
Our main production method for DL-Serine uses controlled synthesis in aqueous conditions. Temperature and pH control in our reactors keeps byproduct levels extremely low. Downstream, purification by recrystallization strips away any off-stoichiometry, keeping chloride and sulfate impurities below 0.05%. Final drying achieves a white, free-flowing powder, confirming long shelf life and ease of handling. Our process avoids cross-contamination with other amino acids or byproducts, which is a common concern at traders who repackage bulk products from multiple origins.
We typically supply DL-Serine in models corresponding to required particle sizes and purity ranges. Most lab and production uses benefit from a standard purity of ≥99.0% (HPLC), fitting pharmacopeia benchmarks and university lab requirements. For pharmaceutical development, grades verified by amino acid analysis assure confidence, matching US and EU pharmacopeia criteria for both content and trace metal limits.
Food industry partners turn to our food-grade DL-Serine, produced under GMP conditions, for their nutraceutical blends and amino acid supplements. Purity and traceability matter in these markets. Every step is documented from raw input to packaged output, and all batches come with full trace analysis: heavy metals (pb, as, hg, cd), microbial load, solubility, and moisture content kept under 0.2%.
Particle size really does matter for certain customers: fine mesh types disperse better in liquid systems, while coarser grades (40–80 mesh) suit tablet manufacturing. Orders can specify packaging—double-layer PE bags with desiccant inside fiber drums to guard against humidity during shipping, or smaller lots in glass bottles for analytical labs. We listen to actual process needs rather than pushing standard options.
Our team hears varied needs from industries daily. In pharma, synthesis chemists depend on DL-Serine both as a chiral building block and a buffer component in peptide manufacturing. Bio-researchers choose the racemic mix to explore activity differences between D- and L-enantiomers on enzyme function or cell signaling. Food technologists incorporate DL-Serine into amino acid supplements, and sometimes in medical nutrition blends to balance nitrogen loads. The flexibility of the racemic form brings down costs and offers pragmatic utility.
We often help clients decide between DL-Serine and L-Serine. L-Serine, being optically pure, plays a critical role in clinical and nutritional settings. DL-Serine, offering both isomers, becomes appealing in synthetic chemistry or early-stage discovery work, where price and chirality separation are less significant. Our technical support team often answers queries about which form suits a process best, drawing on our analytics data and customer feedback. We rarely see practical demand for pure D-Serine except in specialist neuroscience research, since suppliers worldwide typically price that product much higher.
In our plant, we manage the differences in demand by keeping DL-Serine lines separate from those producing optically pure L-Serine. This addresses two needs at once: it preserves quality for both standard and high-purity products, and it ensures traceability and compliance in audits. Customers appreciate this attention to detail, especially when seeking ingredients for US FDA or EU EFSA applications.
Anyone in the supply chain can claim “99% purity,” so we put real work into validating and documenting our product. We use consistent HPLC, melting point, and NMR checks on every lot, not only as a matter of formal QA but to ensure peace of mind for labs relying on us. Customer audits challenge manufacturers to explain these processes face-to-face. Unlike traders handling finished goods from many bulk origins, we provide full batch records, perspectives on raw material sources, and answer technical questions directly from our chemists.
Our plant ramps up production volumes for seasonal contracts and international tenders; we do not blend left-over lots or shortcut stability testing. About 80% of our output ships under strict non-repackaging terms, since once the package leaves our control, keeping contamination out becomes more difficult. Regular customers often tour our facility to see these steps firsthand. This transparency matters to formulation labs who cannot accept risk from inconsistent material or supplier ambiguity.
The only way we stay in business is to learn from usage feedback and product returns. For instance, in the past, moisture levels rose above optimal values in some summer shipments. Since then, storage and packaging protocols were tightened, and all finished goods pass a moisture analysis before sealing drums. Customer return rates on DL-Serine now sit under 0.2%. Problems do still crop up elsewhere—lost labels, or rare trace impurities—but we tackle these directly with both the lab and logistics partners involved.
DL-Serine, in our experience, does not present serious hazards when stored and handled as any typical amino acid—airtight, in a cool, dry place, away from strong oxidizers. We print full handling instructions and hazard codes (if relevant) on every drum and bottle, along with safety data sheet references. Most regulators view DL-Serine as a low-risk substance, but compliance demands proper labelling and storage records. Our support staff provides up-to-date documentation by request, helping customers streamline their own internal QA paperwork.
Regular compliance updates also play a vital role. We maintain records for all batches produced under local and international guidance, including those requiring Kosher or Halal review. Routine internal and external audits, both scheduled and surprise, reinforce trust with long-term partners. Our team keeps up with any changes in regulatory expectations and incorporates these early on for all production runs destined for critical markets.
DL-Serine’s roles within biochemistry and process industries cover a wide range:
Synthetic peptide manufacturers use DL-Serine extensively for small- to large-scale peptide coupling, especially since both isomers may need to be screened for new effects. In this process, purity, absence of moisture, and solubility in aqueous or organic media directly affect yield and downstream isolation. Small differences in raw amino acid quality become magnified during scaleup, so our process prioritizes strict test intervals and record-keeping.
Cell culture labs demand high consistency for media formulation. Even slight deviations in trace metals or byproducts can change growth rates and results in downstream research. Over the years, feedback from academic and pharmaceutical clients has shaped our quality control. We routinely cross-test against published international standards (EP, USP, JP), and send blind duplicates for third-party verification, reducing the risk of hidden contaminants from overlooked process steps.
In the food industry, our DL-Serine goes both into finished goods (such as supplement tablets and drinks) and as a balancing agent in amino acid mixtures. Here, purity and allergen status take center stage, as cross-contamination could introduce compliance issues. Our production spaces are segregated, minimizing accidental contact with milk, egg, soy, or wheat-derived substances.
We often get asked about the difference between DL-Serine and similar amino acids like L-Serine, glycine, or threonine. The distinctions may seem technical, but they impact outcomes in real-world applications.
DL-Serine’s main difference from L-Serine lies in its racemic nature; you get both D and L isomers in equal measure. This mixture can affect certain biochemical processes and applications. L-Serine, being chiral pure, suits clinical biochemistry, therapeutic formulations, and food-nutritional work, where strict optical purity is mandatory. DL-Serine, on the other hand, finds more use as a flexible intermediate or when chirality separation is unnecessary or uneconomical.
Compared to glycine, DL-Serine offers a side chain with a hydroxymethyl group, facilitating different synthetic reactions and metabolic pathways. Glycine synthesis is less chemically complex, so it sells at lower prices. In many peptide assembly projects, serine is chosen for its reactive side group, while glycine serves as a simple spacer. In media preparation and animal feed, both may appear together, but they behave differently downstream.
Threonine, another hydroxyl-containing amino acid, shares some synthetic and dietary uses with serine but has distinctive structure and cost. Our customers in feed and pharma manufacturing sometimes switch between serine and threonine depending on the biological system they target, production cost, and desired biochemical effect. Our familiarity with all three products allows us to advise on these substitutions without risking trial-and-error in the customer’s own workflow.
One of the advantages of being a primary manufacturer lies in our ability to collaborate closely with research and industrial partners. In early-stage drug discovery, we routinely help biotech customers design experiments using both the D- and L-forms of serine separately or together, delivering custom-formulated lots as needed. Our track record on logistical reliability means research deadlines can be met, and production interruptions avoided. This commitment to hands-on support and direct manufacturer feedback distinguishes us from traders or distributors who lack direct process insight.
Part of our mission includes sharing updates from our own technical studies or customer feedback. We have seen increased focus on NMDA receptor research within neuroscience; D-Serine’s role as a co-agonist makes the racemic DL-Serine a go-to reagent for many up-and-coming groups. We maintain reserves of high-purity, validated DL-Serine to meet such time-sensitive demands, avoiding production downtime that could impact research milestones.
Being close to the technical side, we know the common points of frustration in this field. Batch-to-batch consistency, overlooked impurities, and incomplete documentation have all come up as pain points. We take these seriously, investing in process improvement, equipment upgrades, and staff training as regular parts of our workflow. The result is not only tighter analytical tolerances but fewer delays for our partners who cannot afford to repeat failed experiments due to inconsistent chemicals.
Shipping delays, labeling errors, and communication gaps do surface, especially during seasonal demand surges or cross-border logistics hiccups. Direct customer service and a willingness to investigate issues in detail keep relationships productive, and we regularly review our internal procedures to keep response times tight. We view every feedback opportunity as essential, not just as sales protection but as a practical roadmap for making our processes work better.
Discovery, manufacturing, and clinical practices keep evolving. As regulatory standards rise and industries shift toward traceable, high-purity reagents, we stay ahead by investing in analytical and quality systems that match or exceed expectations. Our own data shows rising demand for L-Serine in therapeutic and nutritional directions, but DL-Serine holds its ground in flexible, cost-sensitive secondary uses. We see new projects using DL-Serine in biocatalysis, fermentation optimization, and synthetic biology, and we’re prepared to adjust production models to suit this next wave.
To serve the next generation of research and production reliably, we keep a clear focus on the details that matter—product integrity, accurate and timely documentation, responsive technical support, and ongoing communication. Our experience manufacturing DL-Serine gives us a clear view of both the challenges and the opportunities that define our shared future in science and industry.